Related Experiment Video
Updated: Mar 26, 2026

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland
Published on: June 7, 2019
Common and distinct features of mammary tumors driven by Pten-deletion or activating Pik3ca mutation
Jeff C Liu1, Dong-Yu Wang2,3, Sean E Egan4,5
1Division of Advanced Diagnostics, Toronto General Research Institute - University Health Network, Toronto, Ontario, Canada.
Abstract:
PTEN loss and PIK3CA activation both promote the accumulation of phosphatidylinositol (3, 4, 5)-trisphosphate (PIP3). While these proteins also have distinct biochemical functions, beyond the regulation of PIP3, little is known about the consequences of these differences in vivo. Here, we directly compared cancer signalling in mammary tumors from MMTV-Cre:Ptenf/f and MMTV-Cre:Pik3ca(LSL-H1047R) mice. Using unsupervised hierarchical clustering we found that whereas MMTV-Cre:Pik3ca(LSL-H1047R)-derived tumors fall into two separate groups, designated squamous-likeEx and class14(Ex), MMTV-Cre:Ptenf/f tumors cluster as one group together with PIK3CA(H1047R) class14(Ex), exhibiting a 'luminal' expression profile. Gene Set Enrichment Analysis (GSEA) of Pten(Δ) and PIK3CA(H1047R) class14(Ex) tumors revealed very similar profiles of signalling pathways as well as some interesting differences. Analysis of 18 signalling signatures revealed that PI3K signalling is significantly induced whereas EGFR signalling is significantly reduced in Pten(∆) versus PIK3CA(H1047R) tumors. Thus, Pten(∆) and PIK3CA(H1047R) tumors exhibit discernable differences that may impact tumorigenesis and response to therapy.
Insights
Loss of PTEN and activation of PIK3CA both increase phosphatidylinositol (3, 4, 5)-trisphosphate) (PIP3) levels in mouse mammary tumors. These genetic changes result in distinct cancer signaling profiles, potentially affecting tumor development and treatment response.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- PTEN loss and PIK3CA activation are common in cancer, both leading to increased phosphatidylinositol (3, 4, 5)-trisphosphate (PIP3) signaling.
- Distinct biochemical functions of PTEN and PIK3CA beyond PIP3 regulation are not well understood in vivo.
Purpose of the Study:
- To directly compare cancer signaling in mammary tumors with PTEN loss versus PIK3CA activation in mice.
- To elucidate the in vivo consequences of PTEN loss and PIK3CA activation beyond PIP3 regulation.
Main Methods:
- Utilized MMTV-Cre:Ptenf/f and MMTV-Cre:Pik3ca(LSL-H1047R) mouse models for mammary tumor generation.
- Employed unsupervised hierarchical clustering to analyze tumor subtypes.
- Conducted Gene Set Enrichment Analysis (GSEA) to compare signaling pathway profiles.
Main Results:
- MMTV-Cre:Pik3ca(LSL-H1047R) tumors segregated into two distinct groups: squamous-likeEx and class14(Ex).
- MMTV-Cre:Ptenf/f tumors clustered with PIK3CA(H1047R) class14(Ex) tumors, showing a 'luminal' expression profile.
- GSEA revealed similar signaling pathway profiles between Pten(Δ) and PIK3CA(H1047R) class14(Ex) tumors, with notable differences in PI3K and EGFR signaling.
Conclusions:
- PTEN loss and PIK3CA activation in mammary tumors lead to distinct, discernible signaling differences.
- These differences in cancer signaling may influence tumorigenesis and response to cancer therapies.
- Further investigation into these distinct pathways is warranted for therapeutic targeting.
More Related Videos
06:06High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
Published on: December 20, 2024
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...